BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 32539744)

  • 1. Anatomical and functional responses in eyes with diabetic macular edema treated with "1 + PRN" ranibizumab: one-year outcomes in population of mainland China.
    Lai K; Huang C; Li L; Gong Y; Xu F; Zhong X; Lu L; Jin C
    BMC Ophthalmol; 2020 Jun; 20(1):229. PubMed ID: 32539744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual Outcomes Following Intravitreal Ranibizumab for Diabetic Macular Edema in a Pro Re Nata Protocol from Baseline: A Real-World Experience.
    James DGP; Mitkute D; Porter G; Vayalambrone D
    Asia Pac J Ophthalmol (Phila); 2019; 8(3):200-205. PubMed ID: 31165603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical coherence tomography biomarkers DROL, PROS, SND, hyperreflective walls of foveal cystoid spaces as predictors of central macular thickness and visual acuity in diabetic macular edema treated with intravitreal ranibizumab.
    Sardana A; Singh K; Singh A; Singh VK
    Indian J Ophthalmol; 2024 May; 72(5):722-727. PubMed ID: 38648434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OCT Angiography Biomarkers for Predicting Visual Outcomes after Ranibizumab Treatment for Diabetic Macular Edema.
    Hsieh YT; Alam MN; Le D; Hsiao CC; Yang CH; Chao DL; Yao X
    Ophthalmol Retina; 2019 Oct; 3(10):826-834. PubMed ID: 31227330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ranibizumab, aflibercept, and dexamethasone implant monotherapy in treatment-naive eyes with diabetic macular edema: A 12-month real-life experience.
    Parca O; Cetin EN
    Indian J Ophthalmol; 2024 May; 72(Suppl 3):S453-S458. PubMed ID: 38648453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subfoveal choroidal thickness changes after intravitreal ranibizumab injections in different patterns of diabetic macular edema using a deep learning-based auto-segmentation.
    Wang XN; Cai X; He S; Zhang X; Wu Q
    Int Ophthalmol; 2023 Dec; 43(12):4399-4407. PubMed ID: 33783677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two different initial treatment regimens of Conbercept in diabetic macular edema: 12-month results from a multicenter randomized controlled study.
    Ren F; Zhang X; Gong H; Tian X; Kong X; Hu Y; Yang J; Shi W; Zhang H; Zhou L; Zhang G
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103745. PubMed ID: 37567331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study).
    Schauwvlieghe AM; Dijkman G; Hooymans JM; Verbraak FD; Hoyng CB; Dijkgraaf MG; Van Leeuwen R; Vingerling JR; Moll AC; Schlingemann RO
    BMC Ophthalmol; 2015 Jul; 15():71. PubMed ID: 26149170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological changes of foveal cysts as a predictor for visual response to anti-vascular endothelial growth factor treatments in diabetic macular edema : Degenerative cyst in DME.
    Tsai MJ; Cheng CK
    Int Ophthalmol; 2023 Aug; 43(8):2751-2762. PubMed ID: 36939978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choroidal Neovascularization Associated with Multiple Evanescent White Dot Syndrome Treated with Intravitreal Ranibizumab.
    Battaglia Parodi M; Iacono P; Zucchiatti I; Bandello F
    Ocul Immunol Inflamm; 2018; 26(4):608-611. PubMed ID: 27892746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro re nata anti-VEGF treatment in pachychoroid neovasculopathy compared with age-related macular degeneration based on optical coherence tomography.
    Üney G; Hazırolan D; Ünlü N; Candan Ö
    Int Ophthalmol; 2024 Mar; 44(1):164. PubMed ID: 38551696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema.
    Moreno JB; Medina DB; Rosellón-Escobar MF; García-Aguirre JG
    BMC Ophthalmol; 2024 Mar; 24(1):113. PubMed ID: 38462613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preserving visual acuity: a compelling 12-year case study of controlling neovascular age-related macular degeneration.
    Tomás RO; Campos A; Oliveira N; Soares P; Sousa JP
    BMC Ophthalmol; 2024 Mar; 24(1):123. PubMed ID: 38494487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anatomical and functional outcomes of the "3+PRN" therapeutic protocol in the treatment of diabetic macular edema].
    Ammari W; Chaabene H; Messaoud R
    J Fr Ophtalmol; 2024 Jun; 47(7):104234. PubMed ID: 38875945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal fasudil monotherapy for treatment of refractory diabetic macular edema: A prospective interventional case series.
    Nourinia R; Nouri H; Abtahi SH; Nakao S; Eslamipour J; Gerami E; Ahmadieh H
    J Fr Ophtalmol; 2023 Nov; 46(9):1055-1060. PubMed ID: 37620196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological Biomarkers Related to Visual Acuity in Patients With Radiation Retinopathy Treated With Intravitreal Ranibizumab.
    Corona ST; Ali OI; Yu HJ; Schefler AC;
    Ophthalmic Surg Lasers Imaging Retina; 2024 May; 55(5):255-262. PubMed ID: 38408221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-World Outcomes of a Loading Phase with Intravitreal Faricimab in Neovascular Age-Related Macular Degeneration (n-AMD) and Diabetic Macular Edema (DME).
    Giancipoli E; Guglielmi A; Bux AV; Clima GME; Pignatelli F; Boscia F; Viggiano P; Boscia G; Fortunato F; Besozzi G; Niro A; Dore S; Iaculli C
    Ophthalmol Ther; 2024 Jun; ():. PubMed ID: 38831127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-life experience of ranibizumab therapy for neovascular age-related macular degeneration from Turkey.
    Cebeci Z; Yilmaz YC; Kir N
    Int J Ophthalmol; 2018; 11(2):267-273. PubMed ID: 29487818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete Posterior Vitreous Detachment Reduces the Need for Treatment of Diabetic Macular Edema.
    Anderson W; Piggott K; Bao YK; Pham H; Kavali S; Rajagopal R
    Ophthalmic Surg Lasers Imaging Retina; 2019 Nov; 50(11):e266-e273. PubMed ID: 31755977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical mecamylamine for diabetic macular edema.
    Campochiaro PA; Shah SM; Hafiz G; Heier JS; Lit ES; Zimmer-Galler I; Channa R; Nguyen QD; Syed B; Do DV; Lu L; Monk J; Cooke JP; Kengatharan MK; Hsu HH
    Am J Ophthalmol; 2010 May; 149(5):839-51.e1. PubMed ID: 20189159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.